C. Lair

Targeting DnaN for tuberculosis therapy using novel griselimycins

H. Matter, D. Heinz, R. Müller, 2015, Science.

Effects of divalent cations and of a calcimimetic on adrenocorticotropic hormone release in pituitary tumor cells.

D. Gully, J. Maffrand, C. Lair, 1997, Biochemical and biophysical research communications.

Identification and optimization of a new series of anti-tubercular quinazolinones.

B. Scheiper, J. Ménegotto, A. Bauer, 2016, Bioorganic & medicinal chemistry letters.

Phencyclidine-like effects of tetrahydroisoquinolines and related compounds.

P. Contreras, S. Mick, C. Lair, 1989, Journal of medicinal chemistry.

Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents

N. Fotouhi, J. Sacchettini, M. Yusupov, 2023, Cell.

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization.

G. Griebel, J. Simiand, P. Soubrié, 2002, The Journal of pharmacology and experimental therapeutics.

Identification and optimization of a new series of anti-tubercular quinazolinones.

B. Scheiper, J. Ménegotto, A. Bauer, 2016, Bioorganic & medicinal chemistry letters.